No 01 2022

Zelluna has developed, scaled and automated its manufacturing process for its TCR-NK cell therapies.

RWK Bidco AB, a newly formed company indirectly wholly owned by KKR Funds, hereby announces a recommended public tender offer to the shareholders of Biotage to transfer all of the ordinary shares of Biotage to RWK BidCo for SEK 145 in cash per ordinary share.

“To be able to control costs and serve patients, the world will need biosimilars,” says Róbert Wessman, Icelandic businessman and entrepreneur.

The new institute, AI Science Institute, brings together researchers, industry and technology developers to further strengthen knowledge development and practical application of artificial intelligence.

Ahead of the EU Commission's presentation of a new strategy for life sciences, four industry organizations in Sweden, Lif – the research-based pharmaceutical companies, SwedenBIO, IKEM, and Swedish Medtech, have submitted a joint statement.

The European Commission has granted BioArctic’s partner Eisai’s application for Marketing Authorization of Leqembi (lecanemab) in the European Union (EU).

Nykode announces that Michael Engsig, CEO, Agnete Fredriksen, CSO & Co-founder, and Harald Gurvin, CFO, have withdrawn their recent resignations and will continue with Nykode.